The following is a summary of “Single-nucleus RNA-sequencing Reveals a MET+ Oligodendrocyte Subpopulation that Promotes ...

A recent study by researchers at Yale University has brought new clarity to what causes DNA changes that lead to cancer. This ...

Treatment options for patients with glioblastoma multiforme (GBM), the most common form of malignant gliomas, now include anti-angiogenic therapy after failure of standard multi-modality treatments.

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

Computed tomography (CT) scans and magnetic resonance imaging (MRI) are commonly utilized to detect brain gliomas and central nervous system inflammation diseases. However, there are instances where ...

Executive Vice President for Health Affairs and Dean of the Duke University School of Medicine Mary Klotman talks with David ...

Glioma is a leading cause of global mortality as the most common primary malignant brain tumor in adults, accounting for over 60% of all intracranial primary tumors. Glioblastoma is known as the most ...

A study presented at the American Society for Radiation Oncology on Oct. 1 offers promise for the treatment of high-grade gliomas using Elekta AB’s Unity MR-Linac system.

Scientists at UNIGE and HUG have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue. Glioblastoma is the most common and most aggressive primary brain ...

Glioblastoma is one of the most serious brain diseases known. More than 45% of brain cancers are gliomas. Only half of ...

Rigel Pharma surged 50.1% due to strong revenue drivers, strategic partnerships, and undervaluation, justifying a Strong Buy ...